Stockreport

Epizyme Has One FDA Approval Down, One More To Go In Coming Months [Seeking Alpha]

Epizyme, Inc.  (EPZM) 
Last epizyme, inc. earnings: 2/24 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: epizyme.com
PDF Summary Epizyme received FDA accelerated approval for TAZVERIK for the treatment of patients with relapsed/refractory epithelioid sarcoma. It is estimated that TAZVERIK, [Read more]